These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 1970829

  • 1. Effect of difference in glucose infusion rate on quantification of hepatic glucose production.
    Sheu WH, Hollenbeck CB, Wu MS, Jaspan JB, Chen YD, Reaven GM.
    J Clin Endocrinol Metab; 1990 May; 70(5):1354-60. PubMed ID: 1970829
    [Abstract] [Full Text] [Related]

  • 2. Effect of glipizide treatment on response to an infused glucose load in patients with NIDDM.
    Sheu WH, Jeng CY, Fuh MM, Chen YD, Reaven GM.
    Diabetes Care; 1995 Dec; 18(12):1582-7. PubMed ID: 8722055
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of glucocorticoids on hepatic sensitivity to insulin and glucagon in man.
    Dirlewanger M, Schneiter PH, Paquot N, Jequier E, Rey V, Tappy L.
    Clin Nutr; 2000 Feb; 19(1):29-34. PubMed ID: 10700531
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Regulation of hepatic glucose output by glucose in vivo.
    Müller MJ, Möring J, Seitz HJ.
    Metabolism; 1988 Jan; 37(1):55-60. PubMed ID: 2892114
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Does glucagon increase plasma free fatty acid concentration in humans with normal glucose tolerance?
    Wu MS, Jeng CY, Hollenbeck CB, Chen YD, Jaspan J, Reaven GM.
    J Clin Endocrinol Metab; 1990 Feb; 70(2):410-6. PubMed ID: 1967614
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Somatostatin does not alter insulin-mediated glucose disposal.
    Meneilly GS, Elahi D, Minaker KL, Rowe JW.
    J Clin Endocrinol Metab; 1987 Aug; 65(2):364-7. PubMed ID: 2885337
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Insulin-independent effects of GLP-1 on canine liver glucose metabolism: duration of infusion and involvement of hepatoportal region.
    Dardevet D, Moore MC, Neal D, DiCostanzo CA, Snead W, Cherrington AD.
    Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E75-81. PubMed ID: 15026303
    [Abstract] [Full Text] [Related]

  • 13. Impairment of noninsulin-mediated glucose disposal in the elderly.
    Meneilly GS, Elahi D, Minaker KL, Sclater AL, Rowe JW.
    J Clin Endocrinol Metab; 1989 Mar; 68(3):566-71. PubMed ID: 2563735
    [Abstract] [Full Text] [Related]

  • 14. Increased hepatic glucose production response to glucagon in trained subjects.
    Drouin R, Lavoie C, Bourque J, Ducros F, Poisson D, Chiasson JL.
    Am J Physiol; 1998 Jan; 274(1):E23-8. PubMed ID: 9458743
    [Abstract] [Full Text] [Related]

  • 15. Glucose, insulin and somatostatin infusion for the determination of insulin sensitivity.
    Harano Y, Ohgaku S, Hidaka H, Haneda K, Kikkawa R, Shigeta Y, Abe H.
    J Clin Endocrinol Metab; 1977 Nov; 45(5):1124-7. PubMed ID: 925138
    [Abstract] [Full Text] [Related]

  • 16. Glucagon-like peptide-1 reduces hepatic glucose production indirectly through insulin and glucagon in humans.
    Larsson H, Holst JJ, Ahrén B.
    Acta Physiol Scand; 1997 Aug; 160(4):413-22. PubMed ID: 9338524
    [Abstract] [Full Text] [Related]

  • 17. Regulation of net hepatic substrate balance by phenacylimidazolium ions in the conscious dog.
    Pagliassotti MJ, Colburn CA, Moore MC, Neal DW, Dominianni SJ, Stephens TW, Cherrington AD.
    Diabetes Res; 1993 Aug; 22(3):123-33. PubMed ID: 7915646
    [Abstract] [Full Text] [Related]

  • 18. Peripheral and hepatic resistance to insulin and hepatic resistance to glucagon in uraemic subjects. Studies at physiologic and supraphysiologic hormone levels.
    Schmitz O.
    Acta Endocrinol (Copenh); 1988 May; 118(1):125-34. PubMed ID: 2898853
    [Abstract] [Full Text] [Related]

  • 19. Mechanisms of tumor-induced hypoglycemia with intraabdominal hemangiopericytoma.
    Chung J, Henry RR.
    J Clin Endocrinol Metab; 1996 Mar; 81(3):919-25. PubMed ID: 8772551
    [Abstract] [Full Text] [Related]

  • 20. Mild type II diabetes markedly increases glucose cycling in the postabsorptive state and during glucose infusion irrespective of obesity.
    Efendic S, Karlander S, Vranic M.
    J Clin Invest; 1988 Jun; 81(6):1953-61. PubMed ID: 3290257
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.